uploads///cl anr

How Do Analysts Rate Colgate-Palmolive and Its Peers?

By

Nov. 1 2016, Updated 3:05 p.m. ET

Analyst coverage

Of the 25 analysts covering Colgate-Palmolive (CL), 20% have rated the stock as a “buy” as of October 27, 2016. The stock has been rated as a “hold” by 80% of analysts. No analysts have “sell” recommendations on the stock.

Colgate-Palmolive is a leading consumer products company with some globally recognized brands in its portfolio. The company has been experiencing persistent weakness in its top line due to the impact of foreign currency fluctuations and macroeconomic challenges in certain markets. Colgate-Palmolive constitutes 3.5% of the Consumer Staples Select Sector SPDR ETF (XLP).

Article continues below advertisement

12-month price target

As of October 27, 2016, the 12-month price target for Colgate-Palmolive was $76.65, reflecting a return potential of 8.6%. Atlantic Equities has the highest price target for Colgate-Palmolive at $85 per share, with an “overweight” rating. Bernstein and SunTrust Robinson Humphrey have each set the lowest price target for Colgate-Palmolive at $70.0 per share.

Peer comparison

We’ll start with Procter & Gamble (PG). Out of 27 analysts covering the stock, 55.0% have rated the stock as a “buy,” 41.0% have rated it as a “hold,” and 4.0% have rated it as a “sell.” B. Riley & Co. has set the highest price target for PG at $106.0 per share, and RBC Capital Markets has set the lowest price target for the stock at $76.0 per share.

Next let’s take a look at The Clorox Company (CLX). Out of 17 analysts, 12.0% have rated the stock as a “buy,” 65.0% rated it as a “hold,” and 23.0% have rated it as a “sell.” Argus Research has set the highest price target for CLX at $148.0 per share, and B. Riley & Co. has set the lowest price target for the stock at $109.0 per share.

For Kimberly-Clark Corporation (KMB), 19.0% of 16 analysts have rated the stock as a “buy,” 69.0% have rated it as a “hold,” and 12.0%% have rated it as a “sell.” Société Générale has set the highest price target for Kimberly-Clark at $159.0 per share, and Bernstein has set the lowest price target for the stock at $123.0 per share.

We’ll discuss the company’s valuation in the concluding part of this series.

Advertisement

More From Market Realist